CHRYSTAL THOMPSON: Open Payments
NPI 1316555659 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 35 payments from 17 companies in 2025. Trend: 2023 $693 · 2024 $1,284 · 2025 $873
Food & beverage: $673Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $182 |
| Incyte Corporation | 1 | $100 |
| Novartis Pharmaceuticals Corporation | 4 | $99 |
| AstraZeneca Pharmaceuticals LP | 4 | $78 |
| JAZZ PHARMACEUTICALS INC. | 2 | $69 |
| PharmaEssentia USA Corporation | 3 | $56 |
| Daiichi Sankyo Inc. | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| BeOne Medicines USA, Inc. | 2 | $36 |
| PFIZER INC. | 2 | $28 |
Products named: DARZALEX, KISQALI, BESREMI, CALQUENCE, TALVEY, KEYTRUDA, CARVYKTI, BRUKINSA.
Industry payments across LA — which companies pay providers there.
